2021
DOI: 10.3390/pharmaceutics13101661
|View full text |Cite
|
Sign up to set email alerts
|

Molecular-Level Release of Coumarin-3-Carboxylic Acid and Warfarin-Derivatives from BSA-Based Hydrogels

Abstract: This investigation aimed at developing BSA hydrogels as a controlled release system to study the release behavior of spin-labeled coumarin-3-carboxylic acid (SL-CCS) and warfarin (SL-WFR). The release profiles of these spin-labeled (SL-) pharmaceuticals from BSA hydrogels prepared with different procedures are compared in detail. The mechanical properties of the gels during formation and release were studied via rheology, while a nanoscopic view on the release behavior was achieved by analyzing SL-drugs–BSA in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(12 citation statements)
references
References 52 publications
0
12
0
Order By: Relevance
“…This helical-structure protein possesses multiple ligand-binding sites, allowing for the tight binding of fatty acids, bilirubin, free metal ions, and a broad spectrum of drugs [43][44][45][46]. Most recently, BSA-based hydrogels with different mechanical properties were evaluated in vitro as delivery systems for coumarin-3carboxylic acid and warfarin, demonstrating the significance of the drug-to-protein ratio, as well as different hydrogel incubation time and gelation procedures, for tunable controlled release [47].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…This helical-structure protein possesses multiple ligand-binding sites, allowing for the tight binding of fatty acids, bilirubin, free metal ions, and a broad spectrum of drugs [43][44][45][46]. Most recently, BSA-based hydrogels with different mechanical properties were evaluated in vitro as delivery systems for coumarin-3carboxylic acid and warfarin, demonstrating the significance of the drug-to-protein ratio, as well as different hydrogel incubation time and gelation procedures, for tunable controlled release [47].…”
Section: Introductionmentioning
confidence: 99%
“…EPR has many advantages over typical methods for drug binding and release studies (i.e., ultracentrifugation, UV-visible spectrophotometry, fluorimetry, Raman spectroscopy), namely a nanomolar detection limit, requirement of extremely small sample volumes (30 µL), sensitivity to protein conformational changes, and experiment time efficiency. Although EPR spectroscopy has not been frequently used for this purpose, since it requires covalent modification of the ligand/drug with a stable radical (EPR-active group), it has been useful for the mechanistic study of HSA-drug association for over 20 different spin-labeled pharmaceuticals [63], as well as for controlled release studies of TEMPO-labeled coumarin-3-carboxylic acid and warfarin from BSA-based hydrogels [47]. Furthermore, the EPR spin labeling technique has also been used to investigate the binding of a mononitrosyl ruthenium complex to HSA, based on its competition with spin-labeled fatty acids for the binding sites on the protein [64], and for monitoring the drug-induced conformational changes in a triazine spin-labeled BSA [65].…”
Section: Introductionmentioning
confidence: 99%
“…Figure 2B shows the BSA hydrogels prepared by thermally and pH-induced methods. In our previous work, BSA hydrogels generated slightly above and slightly below the denaturation temperature (at 65 °C and 59 °C) at pH 7, and by lowering the pH to 3.5 at 37 °C, have been extensively investigated [14,15]. We obtain thermally induced hydrogels by heating the precursor solution of 1000 µL, 5 mM BSA above the denaturation temperature of this protein at 65 °C.…”
Section: Measurement Of Rheological Propertiesmentioning
confidence: 99%
“…To counteract these deficiencies, controlled and sustained drug delivery systems, providing a constant and prolonged drug concentration, have been developed and have attracted significant attention [5]. Several systems, among them nanofibers [6,7], microparticles [8][9][10], smart polymers [11,12], hydrogels [13][14][15], nanocarriers [16], etc., have been explored for drug delivery applications.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation